Clinical trial
Safety Evaluation of Bioactive Glass-Based Bone Cement Combined With Ultrasound in Implantation for Metastatic Bone Tumors
NCT07540468 is registered in ClinicalTrials.gov with Liao Yun as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety Evaluation of Bioactive Glass-Based Bone Cement Combined With Ultrasound in Implantation for Metastatic Bone Tumors
- Lead sponsor
- Liao Yun
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- May 1, 2026
- Completion date
- April 30, 2028
- Enrollment
- 8 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancer, pain